International Therapeutics
Seattle
About International Therapeutics
International Therapeutics, Inc. (ITI) is a privately held Seattle biotechnology company focused on the discovery and development of novel anti-viral therapies. The present focus of the Company is dedicated to finding new, safe and effective ways to combat HIV, a virus infecting over 40 million people worldwide.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $2.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Oct 2001)
- Website: internationaltherapeutics.com
- Phone: 206-329-3563
Industries & Categories
Biotechnology, Therapeutics
Canonical: https://fsome.com/organization/international-therapeutics-2168251 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.